Low anti-Mullerian hormone in reproductive age is associated with MASLD in midlife
Low AMH levels in reproductive-aged women conferred a more than 2-fold higher odds of prevalent MASLD in midlife, independent of metabolic comorbidities. AMH levels may therefore serve as a valuable marker of MASLD risk in young women.
Authors
- Heather Gibson Huddleston (ORCID: https://orcid.org/0000-0001-5350-6951)
- J.G. Terry
- Stephanie S. Maldonado (ORCID: https://orcid.org/0000-0003-2789-4721)
- Monika Sarkar
- Melissa Wellons
- Katherine M. Cooper
Institutions
- University of Massachusetts Chan Medical School (US)
- University of California, San Francisco (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1097/hc9.0000000000000880
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00